167 related articles for article (PubMed ID: 2665869)
41. TTP/HUS: observational studies generate hypotheses that lead to randomized controlled trials.
Clark WF; Forzley BR; Sontrop JM; Kadri A; Moist LM; Suri RS; Salvadori MI; Garg AX
Kidney Int Suppl; 2009 Feb; (112):S50-1. PubMed ID: 19180136
[TBL] [Abstract][Full Text] [Related]
42. [Thrombotic thrombocytopenic purpura in children -- pathophysiologic mechanisms and their clinical significance].
Korczowski B
Med Wieku Rozwoj; 2005; 9(4):753-61. PubMed ID: 16733283
[TBL] [Abstract][Full Text] [Related]
43. Function of von Willebrand factor in children with diarrhea-associated hemolytic-uremic syndrome (D+ HUS).
Sutor AH; Thomas KB; Prüfer FH; Grohmann A; Brandis M; Zimmerhackl LB
Semin Thromb Hemost; 2001 Jun; 27(3):287-92. PubMed ID: 11446662
[TBL] [Abstract][Full Text] [Related]
44. von Willebrand factor-cleaving protease in childhood diarrhoea-associated haemolytic uraemic syndrome.
Hunt BJ; Lämmle B; Nevard CH; Haycock GB; Furlan M
Thromb Haemost; 2001 Jun; 85(6):975-8. PubMed ID: 11434704
[TBL] [Abstract][Full Text] [Related]
45. Increased von Willebrand factor (vWf) binding to platelets associated with impaired vWf breakdown in thrombotic thrombocytopenic purpura.
Moake JL; Chow TW
J Clin Apher; 1998; 13(3):126-32. PubMed ID: 9828023
[TBL] [Abstract][Full Text] [Related]
46. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
Moake JL
Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
[TBL] [Abstract][Full Text] [Related]
47. Expression of a structurally constrained von Willebrand factor variant triggers acute thrombotic thrombocytopenic purpura in mice.
Morioka Y; Casari C; Wohner N; Cho S; Kurata S; Kitano A; Christophe OD; Lenting PJ; Li R; Denis CV; Prévost N
Blood; 2014 May; 123(21):3344-53. PubMed ID: 24713928
[TBL] [Abstract][Full Text] [Related]
48. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
49. Thrombotic microangiopathies: new insights and new challenges.
Zipfel PF; Heinen S; Skerka C
Curr Opin Nephrol Hypertens; 2010 Jul; 19(4):372-8. PubMed ID: 20539230
[TBL] [Abstract][Full Text] [Related]
50. [TTP/HUS and VWF/ADAMTS-13].
Fujimura Y
Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930
[No Abstract] [Full Text] [Related]
51. Thrombotic microangiopathies: towards a pathophysiology-based classification.
Coppo P; Veyradier A
Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):36-50. PubMed ID: 19275576
[TBL] [Abstract][Full Text] [Related]
52. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
53. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and treatment.
George JN; Vesely SK
Cleve Clin J Med; 2001 Oct; 68(10):857-8, 860, 863-4 passim. PubMed ID: 11596624
[TBL] [Abstract][Full Text] [Related]
54. Loss of von Willebrand factor high-molecular-weight multimers at acute phase is associated with detectable anti-ADAMTS13 IgG and neurological symptoms in acquired thrombotic thrombocytopenic purpura.
Béranger N; Benghezal S; Savigny S; Capdenat S; Joly BS; Coppo P; Stepanian A; Veyradier A
Thromb Res; 2019 Sep; 181():29-35. PubMed ID: 31330376
[TBL] [Abstract][Full Text] [Related]
55. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange.
Pereira A; Mazzara R; Monteagudo J; Sanz C; Puig L; Martínez A; Ordinas A; Castillo R
Ann Hematol; 1995 Jun; 70(6):319-23. PubMed ID: 7632812
[TBL] [Abstract][Full Text] [Related]
56. Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura.
Murphy WG; Moore JC; Barr RD; Pai MK; Kelton JG
Br J Haematol; 1987 Aug; 66(4):509-13. PubMed ID: 3499167
[TBL] [Abstract][Full Text] [Related]
57. Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials.
Michael M; Elliott EJ; Craig JC; Ridley G; Hodson EM
Am J Kidney Dis; 2009 Feb; 53(2):259-72. PubMed ID: 18950913
[TBL] [Abstract][Full Text] [Related]
58. Effect of splenectomy on von Willebrand factor multimeric structure in thrombotic thrombocytopenic purpura refractory to plasma exchange.
Pereira A; Monteagudo J; Bono A; Lopez-Guillermo A; Ordinas A
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):783-6. PubMed ID: 8292728
[TBL] [Abstract][Full Text] [Related]
59. [Thrombotic microangiopathy after extracorporeal circulation: important differential diagnosis].
Schmidt T; Tsakiris DA; Grapow M; Siegemund M
Anaesthesist; 2011 May; 60(5):451-6. PubMed ID: 21184040
[TBL] [Abstract][Full Text] [Related]
60. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura.
van der Plas RM; Schiphorst ME; Huizinga EG; Hené RJ; Verdonck LF; Sixma JJ; Fijnheer R
Blood; 1999 Jun; 93(11):3798-802. PubMed ID: 10339486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
